Healthequity (HQY) Non-Current Deffered Revenue (2014 - 2019)

Healthequity's Non-Current Deffered Revenue history runs 6 years deep, the most recent figure standing at $3.0 million for Q1 2019.

• In Q1 2019, Non-Current Deffered Revenue rose 23.92% year-over-year to $3.0 million; the TTM figure through Jan 2019 stood at $3.0 million (up 23.92% YoY), while the FY2019 annual figure was $3.0 million, up 23.92% from the prior year.
• Non-Current Deffered Revenue was $3.0 million for Q1 2019 at Healthequity, up from $2.5 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $3.0 million in Q1 2019 to a low of $145000.0 in Q3 2015.
• Historically, Non-Current Deffered Revenue has averaged $1.3 million across 5 years, with a median of $1.3 million in 2016.
• The sharpest annual moves came in 2015 and 2016: Non-Current Deffered Revenue slumped 66.67% in 2015, then surged 642.07% in 2016.
• A 5-year view of Non-Current Deffered Revenue shows it stood at $195000.0 in 2015, then soared by 564.1% to $1.3 million in 2016, then jumped by 71.89% to $2.2 million in 2017, then grew by 10.78% to $2.5 million in 2018, then increased by 20.36% to $3.0 million in 2019.
• The last three Non-Current Deffered Revenue figures came in at $3.0 million (Q1 2019), $2.5 million (Q2 2018), and $2.4 million (Q1 2018), per Business Quant data.